REGISTERED NUMBER: |
Unaudited Cessation Financial Statements |
for the Period 1 March 2023 to 21 July 2023 |
for |
DFW Pharma Consulting Limited |
REGISTERED NUMBER: |
Unaudited Cessation Financial Statements |
for the Period 1 March 2023 to 21 July 2023 |
for |
DFW Pharma Consulting Limited |
DFW Pharma Consulting Limited (by shares) (Registered number: 09985422) |
Contents of the Financial Statements |
for the Period 1 March 2023 to 21 July 2023 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
DFW Pharma Consulting Limited (by shares) |
Company Information |
for the Period 1 March 2023 to 21 July 2023 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: | Caroola Accountancy Limited |
840 Ibis Court |
Centre Park Square |
Warrington |
WA1 1RL |
DFW Pharma Consulting Limited (by shares) (Registered number: 09985422) |
Balance Sheet |
21 July 2023 |
21/7/23 | 28/2/23 |
£ | £ |
CURRENT ASSETS |
CREDITORS |
Amounts falling due within one year | ( |
) | ( |
) |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
NOTES TO THE FINANCIAL STATEMENTS |
1. | AVERAGE NUMBER OF EMPLOYEES |
The average number of employees during the period was |
2. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following advances and credits to a director subsisted during the period ended 21 July 2023 and the year ended 28 February 2023: |
21/7/23 | 28/2/23 |
£ | £ |
Balance outstanding at start of period |
Amounts advanced |
Amounts repaid | ( |
) | ( |
) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of period |
The loan is interest bearing, unsecured and has no set repayment terms. |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
DFW Pharma Consulting Limited (by shares) (Registered number: 09985422) |
Balance Sheet - continued |
21 July 2023 |
The financial statements were approved by the Board of Directors and authorised for issue on |